Integrated Specific Pathogen Free Research Models and Human New Approach Methodologies to Advance HIV/AIDS Research (U42 Clinical Trial Not Allowed)

Summary

The National Institutes of Health (NIH) is soliciting applications under a U42 cooperative agreement mechanism to support integrated research combining Specific Pathogen Free (SPF) research models with human New Approach Methodologies (NAMs) to advance HIV/AIDS research. Clinical trials are explicitly excluded from this funding opportunity. The opportunity is currently in a forecasted status, with an anticipated open date of May 20, 2026. No further scope details are provided in the available text.

What they want

Risks & flags

• Forecasted opportunity only — full scope, eligibility, and evaluation criteria not yet available; intelligence is highly incomplete
• U42 mechanism is a cooperative agreement typically used for resource development centers, which may limit the pool of eligible applicants to specialized institutions